{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:37:22Z","timestamp":1787841442608,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060477"],"award-info":[{"award-number":["82060477"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117391","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:49:40Z","timestamp":1759798180000},"page":"117391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P4","title":["Harmine inhibits ovarian cancer migration and invasion and epithelial-mesenchymal transition (EMT) by inhibiting HDAC7 to restore RECK expression"],"prefix":"10.1016","volume":"242","author":[{"given":"Yin","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bcp.2025.117391_b0005","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0010","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.bcp.2025.117391_b0015","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12272-020-01283-6","article-title":"Pharmacological effects of Harmine and its derivatives: a review","volume":"43","author":"Zhang","year":"2020","journal-title":"Arch. Pharm. Res."},{"issue":"10","key":"10.1016\/j.bcp.2025.117391_b0020","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1002\/ptr.7933","article-title":"Activation of endoplasmic reticulum stress by Harmine suppresses the growth of esophageal squamous cell carcinoma","volume":"37","author":"Fan","year":"2023","journal-title":"Phytother. Res. PTR"},{"key":"10.1016\/j.bcp.2025.117391_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216142","article-title":"Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGF\u03b2 signaling pathway","volume":"560","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0030","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1038\/s41598-024-57196-7","article-title":"The roles of autophagy, ferroptosis and pyroptosis in the anti-ovarian cancer mechanism of Harmine and their crosstalk","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117391_b0035","first-page":"10","article-title":"Anticancer activities of Harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells","volume":"28","author":"Li","year":"2017","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.bcp.2025.117391_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.980704","article-title":"The \u03b2-carboline Harmine improves the therapeutic benefit of anti-PD1 in melanoma by increasing the MHC-I-dependent antigen presentation","volume":"13","author":"Noman","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117391_b0045","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3892\/or.2017.5952","article-title":"Harmine suppresses the proliferation and migration of human ovarian cancer cells through inhibiting ERK\/CREB pathway","volume":"38","author":"Gao","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0050","first-page":"91","article-title":"HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of \u03b2-catenin-FGF18 pathway","volume":"41","author":"Guo","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0055","first-page":"54","article-title":"Melatonin inhibits ESCC tumours growth by mitigating the HDAC7\/\u03b2-catenin\/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability","volume":"9","author":"Ma","year":"2022","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-022-05522-0","article-title":"HDAC7\/c-Myc signaling pathway promotes the proliferation and metastasis of choroidal melanoma cells","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bcp.2025.117391_b0065","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/onc.2016.337","article-title":"Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer","volume":"36","author":"Witt","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2025.117391_b0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.toxlet.2013.10.035","article-title":"Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells","volume":"224","author":"Kwieci\u0144ska","year":"2014","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/1570161113666151014130746","article-title":"A hypothesis for the role of RECK in angiogenesis","volume":"14","author":"Guti\u00e9rrez","year":"2016","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117391_b0080","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1349-7006.2007.00588.x","article-title":"Recklessness as a hallmark of aggressive cancer","volume":"98","author":"Noda","year":"2007","journal-title":"Cancer Sci."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2025.117391_b0085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10555-007-9093-8","article-title":"RECK\u2013a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer","volume":"26","author":"Clark","year":"2007","journal-title":"Cancer Metastasis Rev."},{"issue":"18","key":"10.1016\/j.bcp.2025.117391_b0090","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161847","article-title":"Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis","volume":"133","author":"Masuda","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2025.117391_b0095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI36541","article-title":"MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization","volume":"119","author":"Vagima","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bcp.2025.117391_b0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0092-8674(01)00597-9","article-title":"The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis","volume":"107","author":"Oh","year":"2001","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2025.117391_b0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/ijms18020258","article-title":"HDAC inhibitors and RECK modulate endoplasmic reticulum stress in tumours cells","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117391_b0110","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/1535-7163.MCT-09-0717","article-title":"Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression","volume":"9","author":"Jeon","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.bcp.2025.117391_b0115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/bbrc.1999.1552","article-title":"Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene","volume":"264","author":"Sasahara","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.bcp.2025.117391_b0120","article-title":"HDAC7: a promising target in cancer","volume":"28","author":"Liu","year":"2024","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117391_b0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2012.06.017","article-title":"Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing","volume":"325","author":"Ahn","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2025.117391_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119112","article-title":"Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK\/AKT pathway","volume":"270","author":"Zhu","year":"2021","journal-title":"Life Sci."},{"issue":"23","key":"10.1016\/j.bcp.2025.117391_b0135","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1038\/s41388-019-0740-7","article-title":"CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation","volume":"38","author":"Zhao","year":"2019","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bcp.2025.117391_b0140","first-page":"3069","article-title":"Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion","volume":"63","author":"Liu","year":"2003","journal-title":"Cancer Res."},{"issue":"40","key":"10.1016\/j.bcp.2025.117391_b0145","doi-asserted-by":"crossref","first-page":"41966","DOI":"10.1074\/jbc.M406320200","article-title":"Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity","volume":"279","author":"Kato","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41420-021-00763-y","article-title":"microRNA-124-3p attenuates myocardial injury in sepsis via modulating SP1\/HDAC4\/HIF-1\u03b1 axis","volume":"8","author":"Wu","year":"2022","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0155","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1080\/21505594.2022.2101746","article-title":"Mycoplasma pneumoniae downregulates RECK to promote matrix metalloproteinase-9 secretion by bronchial epithelial cells","volume":"13","author":"Qin","year":"2022","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.bcp.2025.117391_b0160","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s41598-022-06288-3","article-title":"Suppression of tumours metastasis by a RECK-activating small molecule","volume":"12","author":"Yoshida","year":"2022","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.bcp.2025.117391_b0165","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.4161\/cc.7.18.6671","article-title":"Regulation of Sp1 by cell cycle related proteins","volume":"7","author":"Tapias","year":"2008","journal-title":"Cell Cycle Georget Tex"},{"issue":"6","key":"10.1016\/j.bcp.2025.117391_b0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cellsig.2003.11.001","article-title":"Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK","volume":"16","author":"Chang","year":"2004","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.bcp.2025.117391_b0175","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/neuonc\/noaa103","article-title":"Increased activation of HDAC1\/2\/6 and Sp1 underlies therapeutic resistance and tumours growth in glioblastoma","volume":"22","author":"Yang","year":"2020","journal-title":"Neuro-Oncol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:31:33Z","timestamp":1769477493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"alternative-id":["S0006295225006562"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117391","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harmine inhibits ovarian cancer migration and invasion and epithelial-mesenchymal transition (EMT) by inhibiting HDAC7 to restore RECK expression","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117391"}}